Alilou, M., Prasanna, P., Bera, K., Gupta, A., Rajiah, P., Yang, M., Jacono, F., Velcheti, V., Gilkeson, R., Linden, P., & Madabhushi, A.(2021).A Novel Nodule Edge Sharpness Radiomic Biomarker Improves Performance of Lung-RADS for Distinguishing Adenocarcinomas from Granulomas on Non-Contrast CT Scans.Cancers,13(11),2781.
Khorrami, M., Bera, K., Thawani, R., Rajiah, P., Gupta, A., Fu, P., Linden, P., Pennell, N., Jacono, F., Gilkeson, R., Velchetii, V., & Madabhushi, A.(2021).Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans.European Journal of Cancer,148, 146 - 158.
Vaidya, P., Bera, K., Gupta, A., WAng, X., Corredor-Prada, G., Fu, P., Beig, N., Prasanna, P., Patil, P., Velu, P., Rajiah, P., Gilkeson, R., Feldman, M., Choi, H., Velcheti, V., & Madabhushi, A.(2020).CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.The Lancet Digital Health,2(3),e116-e128.
Vaidya, P., Bera, K., Patil, P., Gupta, A., Jain, P., Alilou, M., Khorrami, M., Velcheti, V., & Madabhushi, A.(2020).Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade.Journal for immunotherapy of cancer,8(2).
Khorrami, M., Prasanna, P., Gupta, A., Patil, P., Velu, P., Thawani, R., Corredor-Prada, G., Alilou, M., Bera, K., Fu, P., & Others, P.(2020).Changes in CT radiomic features associated with lymphocyte distribution predict overall survival and response to immunotherapy in non-small cell lung cancer.Cancer immunology research,8(1),108.
Khorrami, M., Prasanna, P., Gupta, A., Patil, P., Velu, P., Thawani, R., Corredor-Prada, G., Alilou, M., Bera, K., Fu, P., Feldman, M., Velcheti, V., & Madabhushi, A.(2020).Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer.Cancer Immunology Research,8(1),108-119.
Prasanna, P., Khorrami, M., Gupta, A., Patil, P., Khunger, M., Velu, P., Bera, K., Alilou, M., Velcheti, V., & Madabhushi, A.(2019).Intra and perinodular CT delta radiomic features associated with early response to predict overall survival (OS) in immunotherapy-treated non-small cell lung cancer (NSCLC): A multisite multi-agent study..Journal of Clinical Oncology,37(15_suppl),2588-2588.
Beig, N., Patel, S., Prasanna, P., Hill, V., Gupta, A., Correa, R., Bera, K., Singh, S., Partovi, S., Varadan, V., Ahluwalia, M., Madabhushi, A., & Tiwari, P.(2018).Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma.Scientific Reports,8(1).
Wen, D., Nye, K., Zhou, B., Gilkeson, R., Gupta, A., Ranim, S., Couturier, S., & Wilson, D. L.(2018).Enhanced coronary calcium visualization and detection from dual energy chest x-rays with sliding organ registration.Computerized Medical Imaging and Graphics,64, 12--21.
Wen, D., Nye, K., Zhou, B., Gilkeson, R., Gupta, A., Ranim, S., Couturier, S., & Wilson, D. L.(2018).Enhanced coronary calcium visualization and detection from dual energy chest x-rays with sliding organ registration.Computerized Medical Imaging and Graphics,64, 21-Dec.
